Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L T Friedhoff

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Archives of Internal Medicine|May 20, 1998
Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study GroupS L Rogers, R S Doody, R C Mohs, et al.
Schizophrenia Research|December 1, 1992
The determination of the steady-state pharmacokinetic profile of fluphenazine decanoate by gas chromatography/mass spectrometry detectionW M Glazer, L T Friedhoff, S R Marder, et al.
Current Medical Research and Opinion|January 27, 2004
Efficacy of once-daily extended-release lovastatin as compared to immediate-release lovastatin in patients with hypercholesterolemiaP Lukacsko, E J Walters, E I Cullen, et al.
Neurology|January 27, 1998
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study GroupS L Rogers, M R Farlow, R S Doody, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1986
Aztreonam penetration into synovial fluid and boneC M MacLeod, E A Bartley, J O Galante, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1986
Aztreonam concentrations in human tissues obtained during thoracic and gynecologic surgeryT R Beam, R P Galask, L T Friedhoff, et al.
Clinical Pharmacology and Therapeutics|December 1, 1986
Quantitation of drug levels and platelet receptor blockade caused by a thromboxane antagonistL T Friedhoff, J Manning, P T Funke, et al.
British Journal of Clinical Pharmacology|December 5, 1998
Pharmacokinetic and pharmacodynamic profile of donepezil HCl following multiple oral dosesS L Rogers, N M Cooper, R Sukovaty, et al.
Dementia and Geriatric Cognitive Disorders|May 15, 1999
The effects of donepezil in Alzheimer's disease - results from a multinational trialA Burns, M Rossor, J Hecker, et al.
Critical Care Medicine|August 31, 2000
A lipid A analog, E5531, blocks the endotoxin response in human volunteers with experimental endotoxemiaE Bunnell, M Lynn, K Habet, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Archives of Internal Medicine|May 20, 1998
Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study GroupS L Rogers, R S Doody, R C Mohs, et al.
Schizophrenia Research|December 1, 1992
The determination of the steady-state pharmacokinetic profile of fluphenazine decanoate by gas chromatography/mass spectrometry detectionW M Glazer, L T Friedhoff, S R Marder, et al.
Current Medical Research and Opinion|January 27, 2004
Efficacy of once-daily extended-release lovastatin as compared to immediate-release lovastatin in patients with hypercholesterolemiaP Lukacsko, E J Walters, E I Cullen, et al.
Neurology|January 27, 1998
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study GroupS L Rogers, M R Farlow, R S Doody, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1986
Aztreonam penetration into synovial fluid and boneC M MacLeod, E A Bartley, J O Galante, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1986
Aztreonam concentrations in human tissues obtained during thoracic and gynecologic surgeryT R Beam, R P Galask, L T Friedhoff, et al.
Clinical Pharmacology and Therapeutics|December 1, 1986
Quantitation of drug levels and platelet receptor blockade caused by a thromboxane antagonistL T Friedhoff, J Manning, P T Funke, et al.
British Journal of Clinical Pharmacology|December 5, 1998
Pharmacokinetic and pharmacodynamic profile of donepezil HCl following multiple oral dosesS L Rogers, N M Cooper, R Sukovaty, et al.
Dementia and Geriatric Cognitive Disorders|May 15, 1999
The effects of donepezil in Alzheimer's disease - results from a multinational trialA Burns, M Rossor, J Hecker, et al.
Critical Care Medicine|August 31, 2000
A lipid A analog, E5531, blocks the endotoxin response in human volunteers with experimental endotoxemiaE Bunnell, M Lynn, K Habet, et al.
Pageof 4